IntroductionLapatinib, a revolutionary medication, has significantly transformed the landscape of cancer treatment, particularly for advanced breast cancer. It is an oral tyrosine kinase inhibitor that targets the HER2/neu receptor, offering hope to patients with HER2-positive breast cancer, which tends to be more aggressive. The success of Lapatinib is not just a testament to medical research...